다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Contineum Therapeutics Inc (CTNM)
Contineum Therapeutics Inc (CTNM) 뉴스

CTNM

Contineum Therapeutics (CTNM)

Contineum Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CTNM

일자	시간	출처	헤드라인	심볼	기업
2024/12/17	06:05	Business Wire	Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/28	07:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/25	22:05	Business Wire	Contineum Therapeutics to Attend the 7th Annual Evercore HealthCONx Conference	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/21	07:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/19	07:05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/18	22:05	Business Wire	Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/14	06:05	Business Wire	Contineum Therapeutics to Attend Upcoming Investor Conferences	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/07	06:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/07	06:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/11/07	06:05	Business Wire	Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/29	05:05	Business Wire	Contineum Therapeutics to Present at Multiple Upcoming Investor Conferences	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/15	07:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/15	01:46	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/15	01:19	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/14	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/14	05:05	Business Wire	Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/08/01	05:05	Business Wire	Contineum Therapeutics Announces Publication of Encouraging Data in the Proceedings of the National Academy of Sciences on PIPE-307, Its M1 Receptor Selective Inhibitor, in Clinical Development for Relapse-Remitting Multiple Sclerosis	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/25	05:05	Business Wire	Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/05	05:05	Business Wire	Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/04	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/04	06:43	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/04	05:05	Business Wire	Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/06/01	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/30	06:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/30	06:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/30	06:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/21	05:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/21	05:05	Business Wire	Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/17	06:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CTNM	Contineum Therapeutics Inc
2024/05/17	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTNM	Contineum Therapeutics Inc

검색 관련기사 보기:NASDAQ:CTNM

Jpmorgan Chase Financial...

Amundi Euro Corp 0 1y Es...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관